ID
22328
Description
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD) Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: 49653/461, This form is to be performed in/after Screening Period 1, Weeks 2, 1 Month +/- 3 Days, 2 Months, 4 Months, 6 Months +/- 1 week, 8 Months, 10 Months, 12 Months +/- 1 week and Follow Up. Sponsor: GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1
Link
https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1
Keywords
Versions (2)
- 5/30/17 5/30/17 -
- 5/30/17 5/30/17 -
Uploaded on
May 30, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Dosing and Compliance Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
Dosing and Compliance Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
Description
Investigational Product Compliance
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C1321605
Description
Investigational Product
Data type
text
Alias
- UMLS CUI [1]
- C0304229
Description
Start date
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0304229
Description
Stop Date
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1,1]
- C0806020
- UMLS CUI [1,2]
- C0304229
Description
IP Container No.
Data type
float
Alias
- UMLS CUI [1,1]
- C0180098
- UMLS CUI [1,2]
- C0304229
Description
Total number of Tablets Dispensed
Data type
float
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0039225
Description
Total number of Tablets Returned
Data type
float
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0039225
Description
Discontinuation
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0457454
- UMLS CUI [1,2]
- C0304229
Similar models
Dosing and Compliance Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
C0011008 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0040223 (UMLS CUI [2,2])
C0237753 (UMLS CUI [1,2])
C1321605 (UMLS CUI-2)
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])